Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Saliva Test for Cancer Moves Closer

September 1, 2011 7:54 am | News | Comments

A new saliva test can measure the amount of potential carcinogens stuck to a person's DNA, interfering with the action of genes involved in health and disease, and could lead to a commercial test to help determine risks for cancer and other diseases.

TOPICS:

MorphoSys Doses First Patient in Phase 1/2a Trial

September 1, 2011 7:49 am | News | Comments

MorphoSys AG announced that the first patient in a Phase 1/2a clinical trial of its cancer antibody MOR202 has been dosed. MOR202 is directed against a therapeutic target which is highly expressed in blood cancers.

TOPICS:

DSMB Clears ReNeuron for Higher ReN001 Dose

September 1, 2011 7:38 am | News | Comments

ReNeuron Group reports that the Data Safety Monitoring Board for the Phase 1 clinical trial of its ReN001 stem cell therapy for stroke patients has recommended that the trial advances to the evaluation of a higher dose of ReN001.

TOPICS:
Advertisement

Virus Successfully Targets Human Tumors

September 1, 2011 7:26 am | News | Comments

Researchers have reported results from a trial that showed that an intravenously-delivered viral therapy can consistently infect and spread within tumors without harming normal tissues in humans.

TOPICS:

Neutrophils Linked to Spreading Cancer

September 1, 2011 7:20 am | News | Comments

Scientists have shown that a particular white blood cell plays a direct role in the development and spread of cancerous tumors. This work points toward novel strategies for treating early-stage cancers.

TOPICS:

Pfizer Extends Icagen Offer

September 1, 2011 7:13 am | News | Comments

Drugmaker Pfizer Inc. is extending by a day its tender offer for pain drug developer Icagen, after the number of shares tendered by its previous deadline fell just short of what Pfizer needed.

TOPICS:

Ruconest Launches After Final Approval

August 31, 2011 12:21 pm | News | Comments

Pharming Group and Swedish Orphan Biovirum announce that Ruconest (INN conestat alfa), a recombinant version of the human protein C1 inhibitor (C1INH), will launch in The Netherlands after the Dutch regulatory authority gave final approval.

TOPICS:

Copper Deficiency Disorder Treated With Gene Replacement

August 31, 2011 12:17 pm | News | Comments

Gene therapy plus an injection of copper dramatically improved survival in mice with a condition that mimics the often fatal childhood disorder Menkes disease, according to a study by researchers at the National Institutes of Health.

TOPICS:
Advertisement

Diabetes in Mice Treated with Uterine Stem Cells

August 31, 2011 12:12 pm | News | Comments

Researchers funded by the National Institutes of Health have converted stem cells from the human endometrium into insulin-producing cells and transplanted them into mice to control the animals’ diabetes.

TOPICS:

Horizon Pharma Loses $11.6 Million in Second Quarter

August 31, 2011 12:07 pm | News | Comments

Horizon Pharma Inc. recorded an $11.6 million loss in the second quarter, its last quarter before the completion of an initial public offering of stock last month.

TOPICS:

Dr. Reddy's, Pfizer Settle Lipitor Patent Lawsuit

August 31, 2011 12:02 pm | News | Comments

Dr. Reddy's Laboratories Ltd. said on Aug. 31 that it settled a lawsuit brought by Pfizer Inc. over a generic version of Pfizer's cholesterol drug Lipitor.

Drug Study Receives OK from Monitoring Board

August 31, 2011 11:58 am | News | Comments

Keryx Biopharmaceuticals Inc. said on Aug. 31 that an independent monitoring board recommended that its late-stage study of a potential colorectal cancer treatment can continue as planned until it is completed.

Computer Model Developed for Testing Heart-Disease Drugs

August 31, 2011 11:54 am | News | Comments

University of California, Davis researchers developed a computer model to test the effects of medications for arrhythmia, or abnormal heart rhythm, before they are used in patients.

Protein Thermal Shift

August 31, 2011 8:22 am | Product Releases | Comments

Life Technologies is now offering Protein Thermal Shift complete solution, an application for Applied Biosystems real-time PCR systems that enables analysis of protein thermal stability.

TOPICS:

Two-Photon Microscopy

August 31, 2011 8:12 am | Product Releases | Comments

Special Optics offers objective lens solutions optimized for use in two-photon microscopy systems. These apochromatic objectives are customized with high numerical apertures and long working distances for use with various sample sizes and applications.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading